Muscarinic M1 receptor modulators (ACADIA Pharmaceuticals/Vanderbilt University)

N/A

Report date: 2025/05/19 16:12:57
NME

Base Information

Drug NameMuscarinic M1 receptor modulators (ACADIA Pharmaceuticals/Vanderbilt University)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionMuscarinic acetylcholine receptor M1 modulators
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesAcadia Pharmaceuticals IncVanderbilt University
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A